‘Stunning Admission’: Widely Used HPV Vaccine Linked to 4 Autoimmune Disorders

A study comparing nearly 2 million vaccinated and unvaccinated adolescent girls over 10 years found…

Children's Health Defense

A type of human papillomavirus (HPV) vaccine widely used throughout the world, but not in the U.S., may increase the risk of developing four autoimmune disorders, according to a study published last week in Vaccine.

The Colombian retrospective cohort study compared the health records of nearly 2 million vaccinated and unvaccinated adolescent girls over 10 years and found the girls vaccinated with a quadrivalent HPV vaccine were 4.4 times more likely than their unvaccinated counterparts to develop rheumatoid arthritis.

Quadrivalent HPV vaccines target four high-risk strains of HPV, compared with Merck’s Gardasil 9 vaccine, the only HPV vaccine distributed in the U.S., which targets nine strains.

Merck does make a quadrivalent Gardasil vaccine — one of two quadrivalent vaccines licensed by the World Health Organization. The study did not specify the brand of vaccine administered.

The girls in the Colombian study also were 2.76 times more likely to develop juvenile idiopathic arthritis, 2.86 times more likely to develop thyrotoxicosis and 2.54 times more likely to develop idiopathic thrombocytopenic purpura during the 180- and 360-day post-vaccination follow-up period studied.

“There are significantly higher levels of these four autoimmune disorders — in girls who weren’t diagnosed with the disorders before vaccination — in the vaccinated group,” Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense (CHD) told The Defender.

“This is a stunning admission of the immune dysregulation caused by this vaccine,” Hooker said. “At a minimum, this deserves more comprehensive investigation towards a decision whether to pull the vaccine entirely.”

The study adds to a large body of peer-reviewed scientific literature from the U.S., Australia, Denmark and Sweden, France, Japan, and Colombia and statistics published by public health agencies in each of these countries demonstrating associations between HPV vaccination and autoimmune conditions.

HPV vaccination rates in Colombia are extremely low, the authors reported. This is in part because, in 2014, 500 girls in a small town called Carmen de Bolivar reported adverse symptoms, including headache, paresthesia, shortness of breath, chest pain and fainting. Videos of the girls were widely shared on the internet.

As public confidence in the vaccine plummeted, rates went from 80% of girls in 2012 to 14% and 5% for the first and second doses in 2016. A later study classified the response as a “mass psychogenic response” unrelated to the content of the vaccine…